You are viewing: Europe Sleep Apnea Devices Market analysis
Part of: Sleep Apnea Devices Market (Global)

The Europe Sleep Apnea Devices Market was valued at $502.9 Million in 2025 and projected to reach to $978.8 Million by 2030, representing a compound annual growth rate of 10.0%. Europe's sleep apnea oral appliances market is experiencing accelerated growth, supported by advanced healthcare systems, strong regulatory frameworks, and increasing patient awareness.

Europe Sleep Apnea Devices Market Trends and Insights

  • Oral Appliances, including mandibular advancement devices and tongue-retaining mouthpieces, offer a non-invasive alternative to CPAP therapy for mild-to-moderate obstructive sleep apnea patients.
  • The segment's robust 10.0% compound annual growth rate reflects increasing patient preference for comfort and portability, coupled with rising awareness of sleep apnea diagnosis and treatment options. Oral Appliances are gaining market traction due to improved clinical efficacy, enhanced design ergonomics, and growing reimbursement coverage across developed healthcare systems.
  • Between 2025 and 2030, Oral Appliances are expected to capture a larger share of the overall sleep apnea treatment landscape as dentists and sleep specialists expand prescription practices.
  • The segment's growth trajectory outpaces the global market average, positioning Oral Appliances as a high-momentum therapeutic category driven by patient compliance improvements and technological innovation in custom-fit solutions..

Key Market Statistics

  • CAGR (2025-2030) 10.0% CAGR
  • Market Size, 2025 ~USD 502.9 Million
  • Forecast, 2030 ~USD 978.8 Million
  • Geography Europe

Europe Sleep Apnea Devices Market Overview

Market Leadership in Oral Appliances :

Europe's sleep apnea oral appliances market is valued at $502.9 million in 2025, driven by strong adoption of mandibular advancement devices as a preferred alternative to CPAP therapy across the region.

Robust Growth Trajectory :

The European market is projected to reach $978.8 million by 2030, representing a 10% CAGR—outpacing the global average of 7.6% and reflecting increasing patient preference for non-invasive treatment options.

Germany Leads European Market :

Germany dominates the European segment with a market size of $690.5 million, followed by the UK ($599.0 million) and France ($422.5 million), indicating strong healthcare infrastructure and reimbursement support.

Expanding Patient Base :

Rising awareness of sleep apnea diagnosis, improved healthcare access, and favorable reimbursement policies across European nations are driving increased adoption of oral appliances among mild-to-moderate OSA patients.

Europe Sleep Apnea Devices Market Dynamics

  • The region's 10% CAGR significantly exceeds global growth rates, reflecting robust demand for non-invasive treatment alternatives.
  • Key European markets including Germany, UK, and France are investing in sleep medicine infrastructure and expanding reimbursement coverage for oral appliances, creating favorable conditions for market expansion. Looking ahead to 2030, the European market is expected to nearly double in value, driven by technological innovations in device design, growing clinical evidence supporting oral appliance efficacy, and demographic shifts toward an aging population with higher sleep apnea prevalence.
  • Continued emphasis on patient comfort and treatment compliance will further accelerate adoption across the region..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Stryker Corporation
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • JOHNSON & JOHNSON

    Key Takeaways

    • Oral Appliances market is valued at $502.9 million in 2025 and will nearly double to $978.8 million by 2030, driven by 10.0% CAGR.
    • Oral Appliances offer superior patient comfort and portability compared to CPAP devices, driving adoption among mild-to-moderate sleep apnea patients.
    • Oral Appliances benefit from expanding reimbursement policies and increased dentist-led prescription practices across developed markets.
    • Oral Appliances segment growth rate (10.0% CAGR) significantly exceeds the global sleep apnea devices market average (7.6% CAGR).

    Sleep Apnea Devices Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment ORAL APPLIANCES (Type)
    Forecast Period 2025–2030
    Growth Rate CAGR of 7.6% from 2025 to 2030
    Largest Segment THERAPEUTIC DEVICES (Product)
    Market Size Base Year (Billions) ~USD 6.95 (2025)
    Revenue Forecast (Billions) ~USD 10.03 (2030)
    Segments Covered Product, Type

    Europe Sleep Apnea Devices Market Report Segmentation

    2 segment dimensions are covered across the global market.

    By Product

    • Diagnostic Devices
    • Therapeutic Devices

    By Type

    • Accessories
    • Actigraphy Systems
    • Ambulatory Psg Devices
    • Apap Devices
    • Bpap Devices
    • Chin Restraints
    • Clinical Psg Devices
    • Communication Accessories
    • Cpap Devices
    • Cushions
    • Daytime-Nighttime Appliances
    • Facial Interfaces
    • Full-Face Masks
    • Home Sleep Testing Devices
    • Humidifier Accessories
    • Mandibular Advancement Devices
    • Masks
    • Nasal Masks
    • Nasal Pillow Masks
    • Oral Appliances
    • Other Accessories
    • Other Therapeutic Devices
    • Oximeters
    • Pap Devices
    • Power Accessories
    • Psg Devices
    • Sleep Screening Devices
    • Tongue-Retaining Devices
    • Transportation Accessories

    Target Audience

    • Medical Device Manufacturers : Manufacturers need Europe-specific market data to optimize product development, pricing strategies, and market entry decisions across diverse regulatory and reimbursement environments.
    • Healthcare Investors & PE Firms : Investors require detailed European market analysis to identify high-growth opportunities, assess competitive positioning, and evaluate acquisition targets in the sleep apnea devices sector.
    • Hospital & Clinic Administrators : Healthcare facility leaders need market insights to make informed procurement decisions, understand patient demand trends, and optimize sleep medicine service offerings across Europe.
    • Pharmaceutical & Dental Companies : Companies seeking to expand into sleep apnea treatment require Europe-specific market intelligence to understand competitive dynamics and develop regional commercialization strategies.
    • Market Research & Consulting Firms : Research organizations need comprehensive European market data to support client advisory services, competitive benchmarking, and strategic planning initiatives in the sleep apnea sector.

    Key Companies in the Europe Sleep Apnea Devices Market

    CompanyHQOwnershipStrongest segments
    HENRY SCHEINUnited StatesPublic CompanyTherapeutic – Oral Appliances,Therapeutic – PAP Devices (CPAP, APAP, BPAP),Therapeutic – Masks and Consumables,
    ROSSMAX INTERNATIONAL LTDTaiwanPublic CompanyTherapeutic – PAP (CPAP, APAP, BPAP),Therapeutic – Oral Appliances,Therapeutic – Masks,
    SANOFISpainPublic CompanyTherapeutic – PAP (CPAP, APAP, BPAP),Therapeutic – Oral Appliances,Therapeutic – Masks,
    DANAHER CORPORATIONUnited StatesPublic CompanyTherapeutic – PAP (CPAP, APAP, BPAP),Therapeutic – Oral Appliances,Therapeutic – Masks,
    RESMEDUnited StatesPublic CompanyTherapeutic – PAP devices (CPAP, APAP, BPAP),Therapeutic – Masks and interfaces,Therapeutic – Oral appliances,
    KONINKLIJKE PHILIPS N.V.NetherlandsPublic CompanyTherapeutic – PAP (CPAP, APAP, BPAP),Therapeutic – Masks and Interfaces,Therapeutic – Oral Appliances,
    FISHER & PAYKEL HEALTHCARE LIMITEDNew ZealandPublic CompanyTherapeutic – PAP devices (CPAP, APAP, BPAP),Therapeutic – Masks and interfaces,Therapeutic – Oral appliances,
    INSPIRE MEDICAL SYSTEMS, INC.United StatesPublic CompanyTherapeutic – Neurostimulation System (competes with PAP/Oral Appliances/Masks),Diagnostic-Linked Services (competes with PSG/Home Sleep Testing/Oximeter adjacencies),
    SOMNOMEDAustraliaPublic CompanyTherapeutic – Oral Appliances (SomnoDent portfolio, SomMorning Repositioner, SomnoBrux),Adjacencies – Cleaning and maintenance (SomTabs) and related accessories,Non-OSA dental protection (SomnoBrux-only use cases),
    COMPUMEDICS LIMITEDAustraliaPublic CompanyDiagnostic – PSG Systems (lab-based and ambulatory),Diagnostic – Home Sleep Testing & Wearables,Diagnostic – Oximetry and Ancillary Monitoring,
    BMCUnited StatesPrivate CompanyTherapeutic Devices (PAP, Oral Appliances, Masks),Diagnostic Devices (PSG, Home Sleep Testing, Oximeter),Healthcare IT / Workflow Enablement for Sleep Care,
    PROSOMNUS SLEEP TECHNOLOGIESUnited StatesPrivate CompanyTherapeutic – Oral Appliances,Therapeutic – PAP (CPAP, APAP, BPAP),Therapeutic – Masks,

    HENRY SCHEIN

    Henry Schein is a publicly traded United States company founded in 1932 with 25,000 employees.

    ROSSMAX INTERNATIONAL LTD

    Rossmax International Ltd is a publicly traded company based in Taiwan, founded in 1988.

    SANOFI

    Sanofi is a publicly traded pharmaceutical company based in Spain, founded in 1994 with 74,846 employees.

    DANAHER CORPORATION

    Danaher Corporation is a publicly traded United States company founded in 1969 with 59,000 employees.

    RESMED

    ResMed is a publicly traded United States company founded in 1989 with 10,600 employees.

    KONINKLIJKE PHILIPS N.V.

    Koninklijke Philips N.V. is a publicly traded Dutch company founded in 1891 with 64,317 employees.

    FISHER & PAYKEL HEALTHCARE LIMITED

    Fisher & Paykel Healthcare Limited is a publicly traded New Zealand company founded in 1934 with 7,396 employees.

    INSPIRE MEDICAL SYSTEMS, INC.

    Inspire Medical Systems, Inc. is a publicly traded United States company founded in 2007 with 1,333 employees.

    SOMNOMED

    SomnoMed is a publicly traded Australian company founded in 1987 with 300 employees.

    COMPUMEDICS LIMITED

    Compumedics Limited is a publicly traded Australian company founded in 1987 with 175 employees.

    BMC

    BMC is a United States-based private company founded in 1980 with 6,700 employees.

    PROSOMNUS SLEEP TECHNOLOGIES

    ProSomnus Sleep Technologies is a United States-based private company founded in 2016 with 136 employees.

    Europe vs. other regions

    HowEurope compares to the other 3 regional blocs covered in this market.

    Global
    ~USD 109.8 Million · 6.7% wtd CAGR ·
    North America
    ~USD 61 Million · 6.8% wtd CAGR ·
    Asia Pacific
    ~USD 4894.9 Million · 9.1% wtd CAGR ·

    Countries within Europe - compare and drill down

    Country2025 size (native)
    GermanyUSD 690.5 Million
    UKUSD 599 Million
    FranceUSD 422.5 Million
    ItalyUSD 353.5 Million
    SpainUSD 308.3 Million
    Rest Of EuropeUSD 728.1 Million

    Country market size visualization

    Germany
    USD 690.5 Million
    UK
    USD 599 Million
    France
    USD 422.5 Million
    Italy
    USD 353.5 Million
    Spain
    USD 308.3 Million
    Rest Of Europe
    USD 728.1 Million

    Reasons to Buy this Report

    • Regional Market Sizing & Forecasts : Gain precise market valuations for Europe's oral appliances segment with country-level breakdowns for Germany, UK, France, Italy, Spain, and Rest of Europe through 2030.
    • Competitive Landscape Analysis : Understand market dynamics, key players, and competitive positioning specific to European markets where regulatory environments and reimbursement policies differ significantly from global markets.
    • Growth Driver Identification : Identify region-specific factors accelerating the 10% CAGR, including healthcare policy changes, aging demographics, and increasing sleep apnea awareness campaigns across European nations.
    • Investment & Expansion Strategy : Develop targeted market entry and expansion strategies by understanding country-specific opportunities, reimbursement landscapes, and patient adoption patterns across Europe.
    • Regulatory & Reimbursement Insights : Access detailed analysis of European regulatory approvals, CE marking requirements, and national reimbursement policies that influence oral appliance market penetration and pricing strategies.

    Frequently asked questions

    What is the market size of Oral Appliances in 2025?

    Oral Appliances are valued at $502.9 million in 2025, representing a significant segment of the global Sleep Apnea Devices Market.

    What is the projected market size for Oral Appliances by 2030?

    Oral Appliances are forecast to reach $978.8 million by 2030, reflecting nearly 95% growth over the five-year forecast period.

    What is the CAGR for Oral Appliances?

    Oral Appliances are expected to grow at a 10.0% compound annual growth rate from 2025 to 2030, outpacing the global market average.

    Why are Oral Appliances gaining market share?

    Oral Appliances are gaining traction due to superior comfort, portability, improved clinical efficacy, expanding reimbursement coverage, and increased adoption by dental professionals.

    How do Oral Appliances compare to CPAP therapy?

    Oral Appliances provide a non-invasive, portable alternative to CPAP devices with better patient compliance for mild-to-moderate sleep apnea, though CPAP remains the gold standard for severe cases.

    RESEARCH METHODOLOGY

    The study analyzes key market dynamics, such as drivers, opportunities, restraints, challenges, and key player strategies. To track company developments such as acquisitions, product launches and approvals, expansions, agreements, and partnerships of the leading players, the competitive landscape of the sleep apnea devices market is analyzed to evaluate market players on various parameters within the broad categories of business and product strategy. Top-down and bottom-up approaches were used to estimate the market size. The market breakdown and data triangulation were used to estimate the market size of segments and subsegments.

    The four steps involved in estimating the market size are

    Secondary Research

    In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.

    Primary Research

    In the primary research process, various supply and demand sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess prospects.

    The following is a breakdown of the primary respondents:

    Sleep Apnea Devices Market

    Note 1: Others include sales, marketing, and product managers.

    Note 2: Companies are classified into tiers based on their total revenues. As of 2022/2023, Tier 1 = >USD 1 million, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    COMPANY NAME DESIGNATION
    SOMNOmedcis AG (Germany) Country Manager
    ResMed (US) Regional Sales Manager

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of sleep apnea devices in the market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    • The key players in the industry have been identified through extensive secondary research
    • Primary and secondary research has determined the revenues generated by leading players operating in the sleep apnea devices market.
    • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

    Global Sleep Apnea Devices Market Size: Bottom-up and Top-down Approach

    Sleep Apnea Devices Market

    Data Triangulation

    After arriving at the overall market size by applying the abovementioned process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

    Market Definition

    Sleep apnea is a prevalent sleep disorder that is frequently undiagnosed, yet it poses significant health risks. This condition is characterized by intermittent cessation of breathing, which can last from several seconds to minutes, or by irregular breathing patterns. The most predominant form is obstructive sleep apnea (OSA), where anatomical or physiological obstructions impede airflow during sleep. Continuous positive airway pressure (CPAP) devices are commonly used to deliver air at elevated pressure through the nasal passages, effectively counteracting upper airway obstructions and facilitating normal respiration. These interventions are crucial for mitigating the associated morbidities linked with untreated sleep apnea.

    Stakeholders

    • Senior Management
    • Sleep Laboratories, Clinics, & Hospitals
    • Home Care Settings
    • Academic & research institutes
    • Finance/Procurement Department
    • R&D Department

    Report Objectives

    • To define, describe, segment, and forecast the global sleep apnea devices market by product, age group, gender, end user, and region
    • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, challenges, and trends)
    • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall sleep apnea devices market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the market segments with respect to five regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa.
    • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
    • To benchmark players within the market using the proprietary Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business and product excellence

    Get the Full Sleep Apnea Devices Market Report

    Full forecast, segment splits, and company analysis for all Sleep Apnea Devices Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status